BCTXL · BriaCell Therapeutics Corp. · Investor Relations
$0.93
+0.03 (+3.33%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jun 9, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, the Company's ability to continue as a going concern is dependent upon its ability to attain future profitable operations and to continue to obtain the necessary financing to meet its obligations arising from normal business operations when they come due. The uncertainty of the Company's ability to raise such financial capital casts substantial doubt on the Company's ability to continue as a going concern.”View the 10-Q filed Jun 9, 2026
Market Cap
$31.54M
Shares
8.70M
Volume · Oct 21
17.17K
Avg daily vol (44 sessions)
16.3K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
No Investor Relations Content
No press releases or events have been collected for this stock yet.